OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of the P2X7 receptor in tumor-associated inflammation
Elena Adinolfi, Elena De Marchi, Elisa Orioli, et al.
Current Opinion in Pharmacology (2019) Vol. 47, pp. 59-64
Closed Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Extracellular vesicles as tools and targets in therapy for diseases
Mudasir A. Kumar, Sadaf Khursheed Baba, Hana Q. Sadida, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 272

Extracellular ATP: A Feasible Target for Cancer Therapy
Valentina Vultaggio-Poma, Alba Clara Sarti, Francesco Di Virgilio
Cells (2020) Vol. 9, Iss. 11, pp. 2496-2496
Open Access | Times Cited: 187

P2X7 in Cancer: From Molecular Mechanisms to Therapeutics
Romain Lara, Elena Adinolfi, Catherine Α. Harwood, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 136

P2X7 Receptors Amplify CNS Damage in Neurodegenerative Diseases
Péter Illés
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 5996-5996
Open Access | Times Cited: 102

The Role of Purinergic P2X7 Receptor in Inflammation and Cancer: Novel Molecular Insights and Clinical Applications
John Charles Rotondo, Chiara Mazziotta, Carmen Lanzillotti, et al.
Cancers (2022) Vol. 14, Iss. 5, pp. 1116-1116
Open Access | Times Cited: 65

Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death
Xuhui Bao, Liyi Xie
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 42

Control of Metastases via Myeloid CD39 and NK Cell Effector Function
Juming Yan, Xian-Yang Li, Amelia Roman Aguilera, et al.
Cancer Immunology Research (2020) Vol. 8, Iss. 3, pp. 356-367
Open Access | Times Cited: 68

P2X7 promotes metastatic spreading and triggers release of miRNA-containing exosomes and microvesicles from melanoma cells
Anna Pegoraro, Elena De Marchi, Manuela Ferracin, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 12
Open Access | Times Cited: 52

P2X7 Variants in Oncogenesis
Anna Pegoraro, Elena De Marchi, Elena Adinolfi
Cells (2021) Vol. 10, Iss. 1, pp. 189-189
Open Access | Times Cited: 51

Inhibition of P2X7 Purinergic Receptor Ameliorates Fibromyalgia Syndrome by Suppressing NLRP3 Pathway
Ramona D’Amico, Roberta Fusco, Rosalba Siracusa, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6471-6471
Open Access | Times Cited: 42

Role of ATP in Extracellular Vesicle Biogenesis and Dynamics
Marta Lombardi, Martina Gabrielli, Elena Adinolfi, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 40

Untangling Macropore Formation and Current Facilitation in P2X7
Federico Cevoli, B Arnould, Francisco Andrés Peralta, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 10896-10896
Open Access | Times Cited: 13

Modulation of Microglial Function by ATP-Gated P2X7 Receptors: Studies in Rat, Mice and Human
Manju Tewari, Stephanie Michalski, Terrance M. Egan
Cells (2024) Vol. 13, Iss. 2, pp. 161-161
Open Access | Times Cited: 5

P2X7 receptor: a critical regulator and potential target for breast cancer
Xiaodi Zhu, Qianqian Li, Wei Song, et al.
Journal of Molecular Medicine (2021) Vol. 99, Iss. 3, pp. 349-358
Closed Access | Times Cited: 32

The Multifaceted Actions of CD73 During Development and Suppressive Actions of Regulatory T Cells
Meihong Da, Luxia Chen, Alexander Enk, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 20

The impact of the P2X7 receptor on the tumor immune microenvironment and its effects on tumor progression
Yu-ting Zou, Jinyuan Li, Jun-yi Chai, et al.
Biochemical and Biophysical Research Communications (2024) Vol. 707, pp. 149513-149513
Closed Access | Times Cited: 4

P2X receptors in cancer growth and progression
Francesco Di Virgilio, Valentina Vultaggio-Poma, Alba Clara Sarti
Biochemical Pharmacology (2020) Vol. 187, pp. 114350-114350
Closed Access | Times Cited: 32

Animal Models for the Investigation of P2X7 Receptors
Ronald Sluyter, Sahil Adriouch, Stephen J. Fuller, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8225-8225
Open Access | Times Cited: 10

Novel synthesized ionizable lipid for LNP-mediated P2X7siRNA to inhibit migration and induce apoptosis of breast cancer cells
Seyed Hossein Kiaie, Ali Rajabi Zangi, Mohammad Sheibani, et al.
Purinergic Signalling (2024) Vol. 20, Iss. 5, pp. 533-546
Open Access | Times Cited: 3

Human P2X7 receptor variants Gly150Arg and Arg276His polymorphisms have differential effects on risk association and cellular functions in pancreatic cancer
Lara Magni, Haoran Yu, Nynne M. Christensen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3

The P2X7 purinergic receptor: a potential therapeutic target for lung cancer
Qianqian Li, Xiaodi Zhu, Wei Song, et al.
Journal of Cancer Research and Clinical Oncology (2020) Vol. 146, Iss. 11, pp. 2731-2741
Closed Access | Times Cited: 27

Emerging roles of purinergic signaling in anti-cancer therapy resistance
Michele Zanoni, Anna Pegoraro, Elena Adinolfi, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 14

P2X7 Receptor in the Management of Energy Homeostasis: Implications for Obesity, Dyslipidemia, and Insulin Resistance
Roberto Coccurello, Cinzia Volonté
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 22

Neutrophils: fast and furious—the nucleotide pathway
Dominique S. Rubenich, Priscila Oliveira de Souza, Natália Omizzollo, et al.
Purinergic Signalling (2021) Vol. 17, Iss. 3, pp. 371-383
Open Access | Times Cited: 18

The P2X7 Receptor in Oncogenesis and Metastatic Dissemination: New Insights on Vesicular Release and Adenosinergic Crosstalk
Elena Adinolfi, Elena De Marchi, Marianna Grignolo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13906-13906
Open Access | Times Cited: 7

Page 1 - Next Page

Scroll to top